Publications and communications of Jean-Marie RAKIC

Georges, A., Lavergne, A., Mandai, M., Lepiemme, F., Karim, L., Demeulenaere, L., Aguilar Ortmans, D., Schyns, M., Nguyen, L., Rakic, J.-M., Takahashi, M., Georges, M., & Takeda, H. (21 January 2023). Comparing the transcriptome of developing native and iPSC-derived mouse retinae by single cell RNA sequencing. Scientific Reports, 13 (1), 1223. doi:10.1038/s41598-023-28429-y

TRIFFAUX, M.-S., Triffaux, J.-M., & Rakic, J.-M. (August 2022). Arrache-toi les yeux ! A propos d’un cas d’auto-énucléation bilatérale. Revue Médicale de Liège, 77 (1), 456-461.

CHAPELLE, A.-C., RAKIC, J.-M., & Plant, G. (2022). 15th EUNOS Congress. Neuro-Ophthalmology, 46 (Suppl), 1-139. doi:10.1080/01658107.2022.2064188

Schoumacher, M., Lambert, V., Govaerts Bernadette, Rakic, J.-M., Noël, A., & De Tullio, P. (2022). From cohort study to the “real life” in patient’s follow-up and personalized medicine using NMR- based clinical metabolomics; results, issues, problems and prospects: the case of neovascular Age-related Macular Degeneration (nAMD) [Poster presentation]. Metabolomics 2022 Valence, valence, Spain.

CHAPELLE, A.-C., RAKIC, J.-M., & PLANT, G. (27 November 2021). Evaluation of ganglion cells loss in anterior ischaemic optic neuropathies [Poster presentation]. OB 2021.

LAMBERT, V.* , hansen, S.* , Schoumacher, M.* , Lecomte, J., Leenders, J., Hubert, P., Herfs, M., Blacher, S., Carnet, O., Yip, C., BLAISE, P., DUCHATEAU, E., LOCHT, B., THYS, M., CAVALIER, E., GOTHOT, A., Govaerts, B., RAKIC, J.-M., Noël, A.* , & De Tullio, P.*. (2020). Pyruvate dehydrogenase kinase/lactate axis: a therapeutic target for neovascular age-related macular degeneration identified by metabolomics. Journal of Molecular Medicine. doi:10.1007/s00109-020-01994-9
* These authors have contributed equally to this work.

GEORGES, A., Lavergne, A., Mandai, M., Lepiemme, F., Karim, L., Demeulenaere, L., Aguilar Ortmans, D., Schyns, M., Nguyen, L., RAKIC, J.-M., Takahashi, M., Georges, M., & Takeda, H. (2020). Combined analysis of single cell RNA-Seq and ATAC-Seq data reveals putative regulatory toggles operating in native and iPS-derived retina. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/292544. doi:10.1101/2020.03.02.972497

LAMBERT, V., MARECHAL, A., MANGIONE, J., Rakic, J.-M., & DUCHESNE, B. (17 January 2020). Decontamination of whole donor eye globes with a commercial antibiotic cocktail medical device [Poster presentation]. XXXII Annual Meeting of the European Eye Bank Association EEBA, Hannover, Germany.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (11 December 2019). New Insight into exudative Age-related Macular Degeneration (AMD): A Metabolomics Approach [Paper presentation]. nd CIRM Day, Liège, Belgium.

Schoumacher, M., LAMBERT, V., Hansen, S., leenders, J., govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (23 June 2019). New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and patients follow-up [Poster presentation]. Metabolomics 2019, The Hague, Netherlands.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (23 May 2019). New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and patients follow-up [Paper presentation]. 12èmes journées RFMF, Clermont-Ferrand, France.

LAMBERT, V., Schoumacher, M., Lecomte, J., Arslan, D., Leenders, J., Govaerts, B., RAKIC, J.-M., Noël, A., & De Tullio, P. (19 September 2018). Metabolomics for the discovery of new therapeutic approach and personalized medicine: the case of exudative Age-related Macular Degeneration [Paper presentation]. Benelux metabolomics Days, Netherlands.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (19 September 2018). NMR-based metabolomics study of Age-related Macular Degeneration (AMD): patient follow-up and new target discovery [Poster presentation]. Benelux metabolomics Days, Netherlands.

Schoumacher, M., LAMBERT, V., Leenders, J., Roblain, Q., govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (05 July 2018). NMR-based Metabolomics for New Target Discovery and Personalized Medicine: Application to Age-Related Macular Degeneration (AMD) [Paper presentation]. EUROMAR (European Magnetic Resonance Meeting), Nantes, France.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (24 June 2018). NMR-Based metabolomics study of Age-related Macular Degeneration (AMD): from pre-clinic model to new target discovery [Poster presentation]. Metabolomics 2017, Seattle, United States.

Schoumacher, M., LAMBERT, V., Govaerts, B., Rakic, J.-M., Noël, A., & De Tullio, P. (23 May 2018). New insight in Metabolomics based study of Age Related Macular Degeneration (AMD): Lipoprotein profile and subclass analysis [Poster presentation]. 11e JS du RFMF, Liege, Belgium.

CHAPELLE, A.-C., & Rakic, J.-M. (2018). Les pathologies vasculaires oculaires : ouvrez l'oeil ! Revue Médicale de Liège, 73 (5-6), 351-358.

Mandal, J., Roth, M., Papakonstantinou, E., Sun, Q., Costa, L., Boeck, L., Scherr, A., Rakic, J.-M., Louis, R., Milenkovic, B., Boersma, W., Kostikas, K., Blasi, F., Aerts, J., Rohde, G., Lacoma, A., Torres, A., Welte, T., Tamm, M., & Stolz, D. (2018). Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD. Pulmonary Pharmacology and Therapeutics, 48, 111-116. doi:10.1016/j.pupt.2017.10.011

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (02 October 2017). New Translational Metabolomics Exploration of Age-Related Macular Degeneration: From Patients to Functional Implication of Lactate [Poster presentation]. SMMAP 2017, Paris, France.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (02 October 2017). New translational metabolomics exploration of age-related macular degeneration: from patients to functional implication of lactate [Paper presentation]. SMMAP 2017, Paris, France.

Schoumacher, M., Lambert, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., RAKIC, J.-M., Noël, A., & De Tullio, P. (14 September 2017). Drug Target Discovery for Age-Related Macular Degeneration (AMD) Through a Metabolomics Approach [Poster presentation]. Journées Franco-Belges de Pharmacochimie, SPA, Belgium.

Schoumacher, M., LAMBERT, V., Hansen, S., Leenders, J., Govaerts, B., Pirotte, B., Rakic, J.-M., Noël, A., & De Tullio, P. (27 June 2016). New Insight into exudative Age-related Macular Degeneration (AMD): A Metabolomics Approach [Poster presentation]. Metabolomics 2016, Dublin, Ireland.

Schoumacher, M., De Tullio, P., LAMBERT, V. (Other coll.), Hansen, S. (Other coll.), Leenders, J. (Other coll.), Govaerts, B. (Other coll.), Pirotte, B. (Other coll.), RAKIC, J.-M. (Other coll.), & Noël, A. (Other coll.). (May 2016). From Metabolomics to Identification of a new therapeutic approach for Age-Related Macular Degeneration (AMD) [Poster presentation]. JFB 2016 : 30èmes Journées Franco-Belges de Pharmacochimie, Amboise, France.

CHAPELLE, A.-C., BLAISE, P., & RAKIC, J.-M. (2016). La sclérite postérieure. Revue Médicale de Liège.

CHAPELLE, A.-C., Locht, B., CROMMEN, J., & RAKIC, J.-M. (2016). An evaluation of diabetic retinopathy screening procedure using a non mydriatic camera [Poster presentation]. OB congress.

Brédart, S., Cornet, A., & RAKIC, J.-M. (30 May 2014). Recognition Memory for Colored and Blackand- White Scenes in Normal and Color Deficient Observers (Dichromats). PLoS ONE, 9 (5), 98757. doi:10.1371/journal.pone.0098757

Rémont, L., Duchesne, B., La, C., Rakic, J.-M., & Hick, S. (2014). Nouvelles approches des greffes de cornée. Revue Médicale de Liège, 69 (9), 490-6.

Arslan, D., Dilly, S., LAMBERT, V., Hansen, S., RAKIC, J.-M., Noël, A., Govaerts, B., Pirotte, B., & De Tullio, P. (06 June 2013). Age-related Macular Degeneration (AMD): from Metabolomics approach to the inhibition of PDH Kinase as a new therapeutic target [Poster presentation]. 27e Journées franco-belges de Pharmacochimie, Lille, France.

LAMBERT, V., Hansen, S., Rousseau, R., Govaerts, B., Pirotte, B., RAKIC, J.-M., Noël, A., & De Tullio, P. (23 May 2013). Age-related Macular Degeneration Study: A Metabolomics Approach [Paper presentation]. First Belgian-Netherlands Joint Symposium on Metabolomics: Transational approaches in Metabolomics, Spa, Belgium.

Bono, F., De Smet, F., Herbert, C., De Bock, K., Georgiadou, M., Fons, P., Tjwa, M., Alcouffe, C., Ny, A., Bianciotto, M., Jonckx, B., Murakami, M., Lanahan, A. A., Michielsen, C., Sibrac, D., Dol-Gleizes, F., Mazzone, M., Zacchigna, S., Herault, J.-P., ... Carmeliet, P. (2013). Inhibition of Tumor Angiogenesis and Growth by a Small-Molecule Multi-FGF Receptor Blocker with Allosteric Properties. Cancer Cell, 23 (4), 477-88. doi:10.1016/j.ccr.2013.02.019

Detry, B., Blacher, S., Erpicum, C., Paupert, J., Maertens, L., Maillard, C., Munaut, C., Sounni, N. E., LAMBERT, V., Foidart, J.-M., Rakic, J.-M., Cataldo, D., & Noël, A. (2013). Sunitinib inhibits inflammatory corneal lymphangiogenesis. Investigative Ophthalmology and Visual Science, 54 (5), 3082-93. doi:10.1167/iovs.12-10856

Huvelle, H., Duchesne, B., & Rakic, J.-M. (2013). Comment je traite...un oeil rouge. Revue Médicale de Liège, 68 (12), 609-12.

Huvelle, H., Duchesne, B., & Rakic, J.-M. (2013). Comment j'explore ... le diagnostic différentiel d'un oeil rouge. Revue Médicale de Liège, 68 (11), 593-8.

LAMBERT, V., Lecomte, J., Hansen, S., Blacher, S., Alvarez Gonzalez, M.-L., Struman, I., Sounni, N. E., Rozet, E., De Tullio, P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (2013). Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nature Protocols, 8 (11), 2197-2211. doi:10.1038/nprot.2013.135

SOHNGEN, P., BLAISE, P., Duchesne, B., & Rakic, J.-M. (2012). Panophtalmie post-traumatique fulgurante. Revue Médicale de Liège, 67 (9), 449-51.

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Labidi, S., Hilfiker-Kleiner, D., Martial, J., Tabruyn, S., & Struman, I. (March 2011). MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy [Poster presentation]. IVth International Meeting on Angiogenesis, Amsterdam, Netherlands.

Halkein, J., Bovy, N., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Martial, J., Tabruyn, S., & Struman, I. (February 2011). MiR-146a: an angiostatic miRNA with tumor-suppressive properties [Poster presentation]. Keystone Symposia : MicroRNAs and Non-Coding RNAs and Cancer, Banff, Alberta, Canada.

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Labidi, S., Hilfiker-Kleiner, D., Martial, J., Tabruyn, S., & Struman, I. (February 2011). MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy [Poster presentation]. Keystone Symposia : MicroRNAs and Human Disease, Banff, Alberta, Canada.

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., Lambert, V., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (February 2011). microRNA-21 Exhibits Anti-Angiogenic Function by Targeting RhoB Expression in Endothelial Cells [Poster presentation]. Keystone Symposia : MicroRNAs and Non-Coding RNAs and Cancer, Banff, Alberta, Canada.

Halkein, J., Castermans, K., Malvaux, L., Lambert, V., Alvarez Gonzalez, M.-L., Rakic, J.-M., Noël, A., Labidi, S., Hilfiker-Kleiner, D., Martial, J., Tabruyn, S., & Struman, I. (January 2011). MiR-146a an angiostatic miRNA elevated in peripartum cardiomyopathy [Poster presentation]. Giga-Day Symposia, Liège, Belgium.

Lecomte, J., Louis, K., Detry, B., Blacher, S., Lambert, V., Bekaert, S., Munaut, C., Paupert, J., Blaise, P., Foidart, J.-M., Rakic, J.-M., Krane, S. M., & Noël, A. (2011). Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization. Cellular and Molecular Life Sciences, 68, 677-686. doi:10.1007/s00018-010-0476-6

Sabatel, C., Malvaux, L., Bovy, N., Deroanne, C., LAMBERT, V., Alvarez Gonzalez, M.-L., Colige, A., Rakic, J.-M., Noël, A., Martial, J., & Struman, I. (2011). MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells. PLoS ONE, 6 (2), 16979. doi:10.1371/journal.pone.0016979

Bourguignont, A., Blaise, P., Janin, N., & Rakic, J.-M. (2010). Le cas clinique du mois. A propos d'un cas de maladie de von Hippel-Lindau. Revue Médicale de Liège, 65 (2), 62-6.

Dubail, J., Kesteloot, F., Deroanne, C., Motte, P., Lambert, V., Rakic, J.-M., Lapiere, C., Nusgens, B., & Colige, A. (2010). ADAMTS-2 functions as anti-angiogenic and anti-tumoral molecule independently of its catalytic activity. Cellular and Molecular Life Sciences. doi:10.1007/s00018-010-0431-6

Van de Veire, S., Stalmans, I., Heindryckx, F., Oura, H., Tijeras-Raballand, A., Schmidt, T., Loges, S., Albrecht, I., Jonckx, B., Vinckier, S., Van Steenkiste, C., Tugues, S., Rolny, C., De Mol, M., Dettori, D., Hainaud, P., Coenegrachts, L., Contreres, J.-O., Van Bergen, T., ... Carmeliet, P. (2010). Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell, 141 (1), 178-90. doi:10.1016/j.cell.2010.02.039

Lambert, V., Frederich, M., Rousseau, R., Detry, B., Peulen, O., Rakic, J.-M., Noël, A., Pirotte, B., Govaert, B., & De Tullio, P. (August 2008). 1H NMR metabolomic approach of the laser-induced choroidal neovascularization in mice [Poster presentation]. 20th International Symposium on Medicinal Chemistry, Vienne, Austria.

Kuiper, E. J., Roestenberg, P., Ehlken, C., Lambert, V., van Treslong-de Groot, H. B., Lyons, K. M., Agostini, H.-J. T., Rakic, J.-M., Klaassen, I., Van Noorden, C. J. F., Goldschmeding, R., & Schlingemann, R. O. (November 2007). Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock-out mice. Journal of Histochemistry and Cytochemistry, 55 (11), 1139-1147. doi:10.1369/jhc.7A7258.2007

Noël, A., Jost, M., Lambert, V., Lecomte, J., & Rakic, J.-M. (August 2007). Anti-angiogenic therapy of exudative age-related macular degeneration: current progress and emerging concepts. Trends in Molecular Medicine, 13 (8), 345-352. doi:10.1016/j.molmed.2007.06.005

Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2007). Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I. American Journal of Pathology, 171 (4), 1369-80. doi:10.2353/ajpath.2007.070074

Rakic, J.-M., COLLIGNON, N., Duchesne, B., & Van Cauwenberge, F. (2007). Resume d'une décennie de progrès ophtalmologiques. Revue Médicale de Liège, 62 (5-6), 467-70.

van Geest, R. J., Kuiper, E. J., Ehlken, C., Lambert, V., Bloys, H., Lyons, K. M., Agostini, H. J. T., Rakic, J.-M., Klaassen, I., van Noorden, C. J. F., Goldschmeding, R., & Schlingemann, R. O. (2007). Connective tissue growth factor (CTGF) is not involved in angiogenesis in knock out mouse models. European Journal of Ophthalmology, 17 (3, MAY-JUN), 476.

Jost, M., Maillard, C., Lambert, V., Tjwa, M., Blaise, P., Lecomte, J., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., Rakic, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type I (PAI-1) controls bone marrow-dependent and independent vascularization. Acta Clinica Belgica, 61 (2, MAR-APR), 87.

Jost, M., Maillard, C., Lecomte, J., Lambert, V., Tjwa, M., Blaise, P., Alvarez Gonzalez, M.-L., Bajou, K., Blacher, S., Motte, P., Humblet, C., Defresne, M.-P., Thiry, M., Frankenne, F., Gothot, A., Carmeliet, P., RAKIC, J.-M., Foidart, J.-M., & Noël, A. (2006). Plasminogen activator inhibitor type 1 (PAI-1) controls bone marrow-dependent and independent vascularization [Poster presentation]. Meeting ABEC/BVSK.

Dubail, J., Kesteloot, F., Motte, P., Lambert, V., Rakic, J.-M., Lapiere, C. M., Nusgens, B., & Colige, A. (2005). ADAMTS-2, a metalloproteinase containing a disintegrin domain and thrombospondin type I repeats, a new regulator of angiogenesis. Journal of Vascular Research, 42 (Suppl. 2), 76.

Xhauflaire, G., Uhoda, E., & Rakic, J.-M. (2005). Oeil et lumiere ultraviolette. Revue Médicale de Liège, 60 (Suppl 1), 99-102.

Blaise, P., Duchateau, E., Duchesne, B., Poutchinian, Y., & Rakic, J.-M. (December 2004). Les occlusions vasculaires retiniennes: diagnostic et prise en charge. Revue de Médecine Interne, 25 (12), 881-90. doi:10.1016/j.revmed.2004.03.010

Dubail, J., Kesteloot, F., Motte, P., Lambert, V., Rakic, J.-M., Lapière, C. M., Nusgens, B., & Colige, A. (2004). Effect of ADAMTS-2, a metalloproteinase containing a disintegrin domain and thrombospondin type I repeats, during angiogenesis in vitro and in vivo. Angiogenesis, 7 (2), 172.

Rakic, J.-M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.-M., Munaut, C., & Noël, A. (July 2003). Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Investigative Ophthalmology and Visual Science, 44 (7), 3186-3193. doi:10.1167/iovs.02-1092

Lambert, V., Munaut, C., Carmeliet, P., Gerard, R. D., Declerck, P. J., Gils, A., Claes, C., Foidart, J.-M., Rakic, J.-M., & Noël, A. (June 2003). Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type 1: Implications for clinical trials. Investigative Ophthalmology and Visual Science, 44 (6), 2791-2797. doi:10.1167/iovs.02-1179

Lambert, V., Wielockx, B., Munaut, C., Werb, Z., Baker, A., Foidart, J.-M., Noël, A., & Rakic, J.-M. (May 2003). Severe inhibition of choroidal neovascularization in mice with a combined deficiency of MMP-2 and MMP-9 genes. Investigative Ophthalmology and Visual Science, 44 (Suppl. 2), 410.

Rakic, J.-M., Lambert, V., Munaut, C., Bajou, K., Peyrollier, K., Alvarez Gonzalez, M.-L., Carmeliet, P., Foidart, J.-M., & Noël, A. (April 2003). Mice without uPA, tPA, or plasminogen genes are resistant to experimental choroidal neovascularization. Investigative Ophthalmology and Visual Science, 44 (4), 1732-1739. doi:10.1167/iovs.02-0809

Rakic, J.-M., Maillard, C., Jost, M., Bajou, K., Masson, V., Devy, L., Lambert, V., Foidart, J.-M., & Noël, A. (March 2003). Role of plasminogen activator-plasmin system in tumor angiogenesis. Cellular and Molecular Life Sciences, 60 (3), 463-473. doi:10.1007/s000180300039

Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Itoh, T., Werb, Z., Baker, A., Krell, H. W., Foidart, J.-M., Rakic, J.-M., libert, C., & Noël, A. (2003). MMP-2 and MMP-9 synergize in promoting choroidal neovascularization. FASEB Journal, 17 (15), 2290-2292. doi:10.1096/fj.03-0113fje

Rakic, J.-M., Lambert, V., Deprez, M., Foidart, J.-M., Noël, A., & Munaut, C. (2003). Estrogens reduce the expression of YKL-40 in the retina: Implications for eye and joint diseases. Investigative Ophthalmology and Visual Science, 44 (4), 1740-1746. doi:10.1167/iovs.02-0775

Lambert, V., Munaut, C., Jost, M., Werb, Z., Foidart, J.-M., Rakic, J.-M., & Noël, A. (October 2002). Matrix metalloproteinase-9 contributes to choroidal neovascularization. American Journal of Pathology, 161 (4), 1247-1253. doi:10.1016/S0002-9440(10)64401-X

Lambert, V., Munaut, C., Frankenne, F., Bajou, K., Gerard, R., Carmeliet, P., Defresne, M.-P., Foidart, J.-M., Rakic, J.-M., & Noël, A. (April 2001). Influence of Plasminogen Activator Inhibitor Type 1 on Choroidal Neovascularization. FASEB Journal, 15 (6), 1021-7. doi:10.1096/fj.00-0393com

Munaut, C., Lambert, V., Noël, A., Frankenne, F., Deprez, M., Foidart, J.-M., & Rakic, J.-M. (2001). Presence of Oestrogen Receptor Type Beta in Human Retina. British Journal of Ophthalmology, 85 (7), 877-82. doi:10.1136/bjo.85.7.877

Noël, A., Bajou, K., Masson, V., Frankenne, F., Rakic, J.-M., Lambert, V., Carmeliet, P., & Foidart, J.-M. (1999). Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1. Fibrinolysis and Proteolysis, 13 (6), 220-225. doi:10.1054/fipr.2000.0043